Page 1609 - Williams Hematology ( PDFDrive )
P. 1609

1584           Part XI:  Malignant Lymphoid Diseases                                                                                                                Chapter 95:  General Considerations for Lymphomas            1585




                 48.  Anderson RE, Nishiyama H, Ii Y, et al: Pathogenesis of radiation-related leukaemia and     82.  Chen MH, Hsiao LT, Chiou TJ, et al: High prevalence of occult hepatitis B virus
                  lymphoma. Speculations based primarily on experience of Hiroshima and Nagasaki.     infection in patients with B cell non-Hodgkin’s lymphoma. Ann Hematol 87:475–480,
                  Lancet 1:1060–1062, 1972.                              2008.
                 49.  Beebe GW, Kato H, Land CE: Studies of the mortality of A-bomb survivors: 6. Mortality     83.  de Sanjose S, Benavente Y, Vajdic CM, et al: Hepatitis C and non-Hodgkin lymphoma
                  and radiation dose, 1950–1974. Radiat Res 75:138–201, 1978.  among 4784 cases and 6269 controls from the International Lymphoma Epidemiology
                 50.  Richardson DB, Sugiyama H, Wing S, et al: Positive associations between ionizing radi-  Consortium. Clin Gastroenterol Hepatol 6:451–458, 2008.
                  ation and lymphoma mortality among men. Am J Epidemiol 169:969–976, 2009.    84.  Schollkopf C, Smedby KE, Hjalgrim H, et al: Hepatitis C infection and risk of malignant
                 51.  Shimizu Y, Kato H, Schull WJ: Risk of cancer among atomic bomb survivors. J Radiat   lymphoma. Int J Cancer 122:1885–1890, 2008.
                  Res 32 Suppl 2:54–63, 1991.                           85.  Inokuchi M, Ito T, Uchikoshi M, et al: Infection of B cells with hepatitis C virus for the
                 52.  Kesminiene A, Evrard AS, Ivanov VK, et al: Risk of hematological malignancies among   development of lymphoproliferative disorders in patients with chronic hepatitis C. J
                  Chernobyl liquidators. Radiat Res 170:721–735, 2008.   Med Virol 81:619–627, 2009.
                 53.  Court-Brown WM, Doll R: Leukaemia and aplastic anaemia in patients irradiated for     86.  Isaacson PG: Update on MALT lymphomas. Best Pract Res Clin Haematol 18:57–68,
                  ankylosing spondylitis. Spec Rep Ser Med Res Counc (G B) 1–135, 1957.  2005.
                 54.  Ron E: Ionizing radiation and cancer risk: Evidence from epidemiology. Radiat Res     87.  Isaacson PG, Spencer J: Gastric lymphoma and  Helicobacter pylori.  Important Adv
                  150:S30–S41, 1998.                                     Oncol 111–121, 1996.
                 55.  Boffetta P, van der Hel O, Kricker A, et al: Exposure to ultraviolet radiation and risk     88.  Mbulaiteye SM, Hisada M, El-Omar EM: Helicobacter pylori associated global gastric
                  of malignant lymphoma and multiple myeloma—A multicentre European case-control   cancer burden. Front Biosci (Landmark Ed) 14:1490–1504, 2009.
                  study. Int J Epidemiol 37:1080–1094, 2008.            89.  Stathis A, Chini C, Bertoni F, et al: Long-term outcome following Helicobacter pylori
                 56.  Colt JS, Rothman N, Severson RK, et al: Organochlorine exposure, immune gene vari-  eradication in a retrospective study of 105 patients with localized gastric marginal zone
                  ation, and risk of non-Hodgkin lymphoma. Blood 113:1899–1905, 2009.  B-cell lymphoma of MALT type. Ann Oncol 20:1086–1093, 2009.
                 57.  Murata K, Yamada Y: The state of the art in the pathogenesis of ATL and new potential     90.  Stefanovic A, Lossos IS: Extranodal marginal zone lymphoma of the ocular adnexa.
                  targets associated with HTLV-1 and ATL. Int Rev Immunol 26:249–268, 2007.  Blood 114:501–510, 2009.
                 58.  Poiesz BJ, Ruscetti FW, Gazdar AF, et al: Detection and isolation of type C retrovirus     91.  Sjo LD, Heegaard S, Prause JU, et al: Extranodal marginal zone lymphoma in the ocu-
                  particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lym-  lar region: Clinical, immunophenotypical, and cytogenetical characteristics.  Invest
                  phoma. Proc Natl Acad Sci U S A 77:7415–7419, 1980.    Ophthalmol Vis Sci 50:516–522, 2009.
                 59.  Jacobson S, Raine CS, Mingioli ES, et al: Isolation of an HTLV-1-like retrovirus from     92.  Ferreri AJ, Dolcetti R, Dognini GP, et al: Chlamydophila psittaci is viable and infectious
                  patients with tropical spastic paraparesis. Nature 331:540–543, 1988.  in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma:
                 60.  Snoda S: Relationship of HTLV-I-related adult T-cell leukemia and HTLV-I-associated   Results of a single-center prospective case-control study. Int J Cancer 123:1089–1093,
                  myelopathy to distinct HLA haplotypes. Jikken Igaku 5:769, 1987.  2008.
                 61.  Wong-Staal F, Gallo RC: The family of human T-lymphotropic leukemia viruses:     93.  Yoo C, Ryu MH, Huh J, et al: Chlamydia psittaci infection and clinicopathologic analy-
                  HTLV-I as the cause of adult T cell leukemia and HTLV-III as the cause of acquired   sis of ocular adnexal lymphomas in Korea. Am J Hematol 82:821–823, 2007.
                  immunodeficiency syndrome. Blood 65:253–263, 1985.    94.  Chan CC, Shen D, Mochizuki M, et al: Detection of Helicobacter pylori and Chlamydia
                 62.  Blattner WA, Kalyanaraman VS, Robert-Guroff M, et al: The human type-C retrovirus,   pneumoniae genes in primary orbital lymphoma. Trans Am Ophthalmol Soc 104:62–70,
                  HTLV, in blacks from the Caribbean region, and relationship to adult T-cell leukemia/  2006.
                  lymphoma. Int J Cancer 30:257–264, 1982.              95.  Ponzoni M, Ferreri AJ, Guidoboni M, et al: Chlamydia infection and lymphomas: Asso-
                 63.  Robert-Guroff M, Kalyanaraman VS, Blattner WA, et al: Evidence for human T cell   ciation beyond ocular adnexal lymphomas highlighted by multiple detection methods.
                  lymphoma-leukemia virus infection of family members of human T cell lymphoma-   Clin Cancer Res 14:5794–5800, 2008.
                  leukemia virus positive T cell leukemia-lymphoma patients. J Exp Med 157:248–258,     96.  Vargas RL, Fallone E, Felgar RE, et al: Is there an association between ocular adnexal
                  1983.                                                  lymphoma and infection with Chlamydia psittaci? The University of Rochester experi-
                 64.  Sarin PS, Aoki T, Shibata A, et al: High incidence of human type-C retrovirus (HTLV)   ence. Leuk Res 30:547–551, 2006.
                  in family members of a HTLV-positive Japanese T-cell leukemia patient. Proc Natl Acad     97.  Yakushijin Y, Kodama T, Takaoka I, et al: Absence of chlamydial infection in Japanese
                  Sci U S A 80:2370–2374, 1983.                          patients with ocular adnexal lymphoma of mucosa-associated lymphoid tissue. Int J
                 65.  Carbone A, Cesarman E, Spina M, et al: HIV-associated lymphomas and gamma-   Hematol 85:223–230, 2007.
                  herpesviruses. Blood 113:1213–1224, 2009.             98.  Zhang GS, Winter JN, Variakojis D, et al: Lack of an association between Chlamydia
                 66.  Epstein MA, Achong BG, Barr YM: Virus particles in cultured lymphoblasts from   psittaci and ocular adnexal lymphoma. Leuk Lymphoma 48:577–583, 2007.
                  Burkitt’s lymphoma. Lancet 1:702–703, 1964.           99.  Chanudet E, Zhou Y, Bacon CM, et al: Chlamydia psittaci is variably associated with
                 67.  Nemerow GR, Wolfert R, McNaughton ME, et al: Identification and characterization   ocular adnexal MALT lymphoma in different geographical regions.  J  Pathol 209:
                  of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the   344–351, 2006.
                  C3d complement receptor (CR2). J Virol 55:347–351, 1985.    100. Verma V, Shen D, Sieving PC, et al: The role of infectious agents in the etiology of ocular
                 68.  Henle W, Diehl V, Kohn G, et al: Herpes-type virus and chromosome marker in normal   adnexal neoplasia. Surv Ophthalmol 53:312–331, 2008.
                  leukocytes after growth with irradiated Burkitt cells. Science 157:1064–1065, 1967.    101. Du MQ: MALT lymphoma: Recent advances in aetiology and molecular genetics. J Clin
                 69.  Andersson M, Klein G, Zeigler JL, et al: Association of Epstein-Barr viral genomes with   Exp Hematop 47:31–42, 2007.
                  American Burkitt lymphoma. Nature 260:357–359, 1976.    102. Cunningham-Rundles C,  Bodian  C: Common variable immunodeficiency: Clinical
                 70.  Potter M, Mushinski JF: Oncogenes in B-cell neoplasia. Cancer Invest 2:285–300, 1984.  and immunological features of 248 patients. Clin Immunol 92:34–48, 1999.
                 71.  Morrow RH Jr: Epidemiological evidence for the role of falciparum malaria in the     103. Dembowska-Baginska B, Perek D, Brozyna A, et al: Non-Hodgkin lymphoma (NHL) in
                  pathogenesis of Burkitt’s lymphoma. IARC Sci Publ 177–186, 1985.  children with Nijmegen Breakage syndrome (NBS). Pediatr Blood Cancer 52:186–190,
                 72.  Klein G: Lymphoma development in mice and humans: Diversity of initiation is fol-  2009.
                  lowed by convergent cytogenetic evolution. Proc Natl Acad Sci U S A 76:2442–2446,     104. Fokin AA, Robicsek F: Poland’s syndrome revisited. Ann Thorac Surg 74:2218–2225,
                  1979.                                                  2002.
                 73.  Klein G: Specific chromosomal translocations and the genesis of B-cell-derived tumors     105. Grobe H: [Dubowitz syndrome and acute lymphatic leukemia] [in German]. Monatsschr
                  in mice and men. Cell 32:311–315, 1983.                Kinderheilkd 131:467–468, 1983.
                 74.  Aozasa K, Takakuwa T, Hongyo T, et al: Nasal NK/T-cell lymphoma: Epidemiology and     106. Holzelova E, Vonarbourg C, Stolzenberg MC, et al: Autoimmune lymphoproliferative
                  pathogenesis. Int J Hematol 87:110–117, 2008.          syndrome with somatic Fas mutations. N Engl J Med 351:1409–1418, 2004.
                 75.  Suzuki R, Takeuchi K, Ohshima K, et al: Extranodal NK/T-cell lymphoma: Diagnosis     107. Kaneko H, Inoue R, Fukao T, et al: Two Japanese siblings with Bloom syndrome gene
                  and treatment cues. Hematol Oncol 26:66–72, 2008.      mutation and B-cell lymphoma. Leuk Lymphoma 27:539–542, 1997.
                 76.  Dotti G, Fiocchi R, Motta T, et al: Primary effusion lymphoma after heart transplanta-    108. Kaneko H, Kondo N: Clinical features of Bloom syndrome and function of the causative
                  tion: A new entity associated with human herpesvirus-8. Leukemia 13:664–670, 1999.  gene, BLM helicase. Expert Rev Mol Diagn 4:393–401, 2004.
                 77.  Gessain A: [Human herpesvirus 8 (HHV-8): Clinical and epidemiological aspects and     109. Kruger L, Demuth I, Neitzel H, et al: Cancer incidence in Nijmegen breakage syndrome
                  clonality of associated tumors] [in French]. Bull Acad Natl Med 192:1189–204; discus-  is modulated by the amount of a variant NBS protein. Carcinogenesis 28:107–111, 2007.
                  sion 204–6, 2008.                                     110. MacGinnitie AJ, Geha R: X-linked lymphoproliferative disease: Genetic lesions and
                 78.  Laurent C, Meggetto F, Brousset P: Human herpesvirus 8 infections in patients with   clinical consequences. Curr Allergy Asthma Rep 2:361–367, 2002.
                  immunodeficiencies. Hum Pathol 39:983–993, 2008.      111. Malkin D, Li FP, Strong LC, et al: Germ line p53 mutations in a familial syndrome of
                 79.  Sullivan RJ, Pantanowitz L, Casper C, et al: HIV/AIDS: Epidemiology, pathophysiol-  breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238, 1990.
                  ogy, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma,       112. Meyn MS: Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene. Clin
                  primary effusion lymphoma, and multicentric Castleman disease.  Clin Infect  Dis   Genet 55:289–304, 1999.
                  47:1209–1215, 2008.                                   113. Mustillo P, Bajwa RP, Termuhlen AM, et al: Tumor immune surveillance defect of
                 80.  Hartridge-Lambert SK, Stein EM, Markowitz AJ, et al: Hepatitis C and non-Hodgkin   X-linked severe combined immunodeficiency is not Epstein-Barr virus specific. Pediatr
                  lymphoma: The clinical perspective. Hepatology 55:634–641, 2012.  Blood Cancer 51:706–709, 2008.
                 81.  Okan V, Yilmaz M, Bayram A, et al: Prevalence of hepatitis B and C viruses in patients     114. Parikh PM, Karandikar SM, Koppikar S, et al: Poland’s syndrome with acute lympho-
                  with lymphoproliferative disorders. Int J Hematol 88:403–408, 2008.  blastic leukemia in an adult. Med Pediatr Oncol 16:290–292, 1988.







          Kaushansky_chapter 95_p1569-1586.indd   1584                                                                  9/21/15   12:17 PM
   1604   1605   1606   1607   1608   1609   1610   1611   1612   1613   1614